Sebastian Zeißig

Active 2004–2025

Also published as
Sebastian Zeissig
61
Papers
19,412
Citations
44
h-index
58
i10-index

Citations

Citations per year for Sebastian Zeißig1986: 1 citations1994: 1 citations2000: 1 citations2005: 3 citations2006: 11 citations2007: 22 citations2008: 25 citations2009: 90 citations2010: 113 citations2011: 126 citations2012: 174 citations2013: 281 citations2014: 416 citations2015: 410 citations2016: 412 citations2017: 411 citations2018: 324 citations2019: 933 citations2020: 928 citations2021: 896 citations2022: 717 citations2023: 529 citations2024: 821 citations2025: 355 citations2026: 11 citations1987–1993: no citations, so these years are not shown1995–1999: no citations, so these years are not shown2001–2004: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,831 citing papers, 23% of this breakdownChina: 1,363 citing papers, 11.1% of this breakdownGermany: 910 citing papers, 7.4% of this breakdownUnited Kingdom: 904 citing papers, 7.4% of this breakdownItaly: 539 citing papers, 4.4% of this breakdownCanada: 496 citing papers, 4% of this breakdownFrance: 489 citing papers, 4% of this breakdownNetherlands: 371 citing papers, 3% of this breakdownJapan: 348 citing papers, 2.8% of this breakdownAustralia: 341 citing papers, 2.8% of this breakdownSpain: 299 citing papers, 2.4% of this breakdownSweden: 273 citing papers, 2.2% of this breakdown
0%23%Other 25.5%

Fields

  • Biochemistry, Genetics and Molecular Biology48.2%
  • Medicine27%
  • Immunology and Microbiology13.8%
  • Neuroscience5%
  • Nursing1.8%
  • Agricultural and Biological Sciences1.5%
  • Other2.7%

Topics

  • Gut microbiota and health9.6%
  • Inflammatory Bowel Disease7.6%
  • Immune Cell Function and Interaction3%
  • Clostridium difficile and Clostridium perfringens research2.6%
  • IL-33, ST2, and ILC Pathways2.2%
  • Microscopic Colitis2.2%
  • Other72.8%

Coauthors

All papers

Open in search
  1. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabrielle Boucher, Stephan Brand, Carsten Büning, Ariella Cohain, Sven Cichon, Mauro D’Amato, Dirk de Jong, Kathy L. Devaney, Marla C. Dubinsky, Cathryn Edwards, David Ellinghaus, Lynnette Ferguson, Denis Franchimont, Karin Fransén, Richard B. Gearry, Michel Georges, Christian Gieger, Jürgen Glas, Talin Haritunians, Ailsa Hart, Chris Hawkey, Matija Hedl, Xinli Hu, Tom H. Karlsen, Limas Kupčinskas, Subra Kugathasan, Anna Latiano, Debby Laukens, Ian C. Lawrance, Charlie W. Lees, Édouard Louis, Gillian Mahy, John Mansfield, Angharad R. Morgan, Craig Mowat, William G. Newman, Orazio Palmieri, Cyriel Y. Ponsioen, Uroš Potočnik, Natalie J. Prescott, Miguel Regueiro, Jerome I. Rotter, Richard K. Russell, Jeremy Sanderson, Miquel Sans, Jack Satsangi, Stefan Schreiber, Lisa A. Simms, Jurgita Šventoraitytė, Stephan R. Targan, Kent D. Taylor, Mark Tremelling, Hein W. Verspaget, Martine De Vos, Cisca Wijmenga, David C. Wilson, Juliane Winkelmann, Ramnik J. Xavier, Sebastian Zeißig, Bin Zhang, Hu Zhang, Hongyu Zhao, Mark S. Silverberg, Vito Annese, Håkon Håkonarson, Steven R. Brant, Graham Radford‐Smith, Christopher G. Mathew, John D. Rioux, Eric E. Schadt and 6 more - Nature 2012 cited by 4,917

  2. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function

    Authors: , , , , , , , , , , - Science 2012 cited by 1,659

  3. Inflammatory Bowel Disease

    Authors: , , - Annual Review of Immunology 2010 cited by 1,763

  4. A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factors

    Authors: , , , , - Cancer Communications 2021 cited by 296

  5. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease

    Authors: , , , , , , , , , - Gut 2006 cited by 1,195

  6. XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease

    Authors: , , , , , , , , , , - Cell 2008 cited by 1,402

  7. Sphingolipids from a Symbiotic Microbe Regulate Homeostasis of Host Intestinal Natural Killer T Cells

    Authors: , , , , , , , , , - Cell 2014 cited by 640

  8. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Deltenre, Henry Völzke, Markus M. Lerch, Julia Mayerle, Florian Eyer, Clemens Schafmayer, Sven Cichon, Markus M. Nöthen, Michael Nothnagel, David Ellinghaus, Klaus Huse, André Franke, Steffen Zopf, Claus Hellerbrand, Christophe Moreno, Denis Franchimont, Marsha Y. Morgan, Jochen Hampe - Nature Genetics 2015 cited by 559

  9. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea E. van der Meulen‐de Jong, Rinse K. Weersma, David C. Wilson, Miles Parkes, Séverine Vermeire, John D. Rioux, John Mansfield, Mark S. Silverberg, Graham Radford‐Smith, Dermot McGovern, Jeffrey C. Barrett, Charlie W. Lees - The Lancet 2015 cited by 778

  10. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Slatter, Peter D. Arkwright, Andrew J. Cant, Hanns‐Martin Lorenz, Thomas Giese, Vassilios Lougaris, Alessandro Plebani, Christina Price, Kathleen E. Sullivan, Michel Moutschen, Jiří Litzman, Tomáš Freiberger, Frank L. van de Veerdonk, Mike Recher, Michael H. Albert, Fabian Hauck, Suranjith L. Seneviratne, Jana Pachlopnik Schmid, Antonios G.A. Kolios, Gary Unglik, Christian Klemann, Carsten Speckmann, Stephan Ehl, Alan M. Leichtner, Richard S. Blumberg, André Franke, Scott B. Snapper, Sebastian Zeißig, Charlotte Cunningham‐Rundles, Lisa Giulino‐Roth, Olivier Elemento, Gregor Dückers, Tim Niehues, Eva Froňková, Veronika Kanderová, Craig D. Platt, Janet Chou, Talal A. Chatila, Raif S. Geha, Elizabeth McDermott, Su Bunn, Monika Kurzai, Ansgar Schulz, Laia Alsina, Ferrán Casals, Àngela Deyà‐Martínez, Sophie Hambleton, Hirokazu Kanegane, Kjetil Taskén, Olaf Neth, Bodo Grimbacher - Journal of Allergy and Clinical Immunology 2018 cited by 441

  11. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer

    Authors: , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 cited by 121

  12. The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2021 cited by 178

  13. Epithelial Tight Junctions in Intestinal Inflammation

    Authors: , , , , , , , , , - Annals of the New York Academy of Sciences 2009 cited by 399

  14. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2012 cited by 624

  15. Loss of hepatic Mboat7 leads to liver fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jochen Hampe, Pallavi Subramanian - Gut 2020 cited by 119

  16. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2018 cited by 208

  17. Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 97

  18. Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn’s Disease

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2019 cited by 95

  19. SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2020 cited by 88

  20. Protective mucosal immunity mediated by epithelial CD1d and IL-10

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 197

  21. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sebastian Zeißig - Immunity 2022 cited by 66

  22. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cancer 2024 cited by 46

  23. Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan R. Bornstein - The Lancet Diabetes & Endocrinology 2023 cited by 33

  24. Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease

    Authors: , - Nature Immunology 2014 cited by 251